Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.
Onconetix has raised $12.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2025.
Onconetix's investors include CincyTech.
Onconetix is headquartered in Cincinnati, United States.
Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.
Onconetix is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Onconetix — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/onconetix. Accessed August 13, 2026.
VCBacked. (2025). Onconetix — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/onconetix
{{cite web |title=Onconetix — Funding & Investors |url=https://www.vcbacked.co/company/onconetix |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated